NCTE Lowers 2026 Revenue and EBITDA Guidance
NCTE lowered its 2026 revenue and EBITDA forecasts. The revenue forecast is 4–4.2; the unit and EBITDA forecast are not specified.
Related stories
Eli Lilly Raises 2026 Sales Outlook on Strong Mounjaro, Zepbound Demand
Eli Lilly raised its full-year sales outlook after third-quarter results topped expectations. Revenue rose 38.6% year over year to $24.4 billion, beating consensus by $1.78 billion
M impact | EARNINGS | Oct 29, 2026, 03:13 PM UTC
Italgas 9M Adjusted Net Profit Rises 18% to €585.5 Million
M impact | EARNINGS | Oct 29, 2026, 03:03 PM UTC
O'Reilly Automotive Raises Full-Year Comparable Store Sales Guidance
O'Reilly Automotive cited robust third-quarter sales and a favorable impact from tariff refunds for the upward revision.
M impact | EARNINGS | Oct 29, 2026, 03:03 PM UTC
Howmet Executive Expects Healthy Volume Increases for Boeing and Airbus Aircraft
A Howmet Aerospace executive said the company expects healthy volume increases for the Boeing 737 and 787 and Airbus A320 and A350.
M impact | EARNINGS | Oct 29, 2026, 03:02 PM UTC
National Corp for Tourism and Hotels Reports 9-Month Profit of 156.1 Million Dirhams
L impact | EARNINGS | Oct 29, 2026, 03:02 PM UTC
Huntington Ingalls reports $3.54 billion revenue and $217 million net income
Revenue rose 10.8% and net income increased 49.7% from the prior-year period. Diluted EPS rose 48.9% to $5.48.
M impact | EARNINGS | Oct 29, 2026, 03:01 PM UTC